MALCY TARIN

Ingénieur d'études

Recherche - Paris

Spécialités / domaines

Research Center,

Translational research

Functions within Institut Curie:

Engineer

DNA Repair and Uveal Melanoma (D.R.U.M)
Unit : Cancer, Heterogeneity, Instability and Plasticity - CHIP (U830)

Publications

2022

Glycolysis Dependency as a Hallmark of SF3B1-Mutated Cells

Cancers

Raquel Vivet-Noguer, Malcy Tarin, Christine Canbezdi, Stephane Dayot, Lisseth Silva, Alexandre Houy, Sylvain Martineau, Virginie Mieulet, Géraldine Gentric, Damarys Loew, Bérangère Lombard, Fariba Nemati, Sophie Richon, Lea Guyonnet, Vincent Servois, Stephan Vagner, Marc-Henri Stern, Sergio Roman-Roman, Samar Alsafadi

(2022 24 Apr)

2021

Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers

Oncogene

Samar Alsafadi, Stephane Dayot, Malcy Tarin, Alexandre Houy, Dorine Bellanger, Michele Cornella, Michel Wassef, Joshua J. Waterfall, Erik Lehnert, Sergio Roman-Roman, Marc-Henri Stern, Tatiana Popova

(2021 07 Jan)

2021

Functional and conformational impact of cancer-associated SF3B1 mutations depends on the position and the charge of amino acid substitution

Computational and Structural Biotechnology Journal

Christine Canbezdi, Malcy Tarin, Alexandre Houy, Dorine Bellanger, Tatiana Popova, Marc-Henri Stern, Sergio Roman-Roman, Samar Alsafadi

(2021 01 Jan)

2020

Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma

European Journal of Cancer

Didier Decaudin, Estelle Frisch Dit Leitz, Fariba Nemati, Malcy Tarin, Adnan Naguez, Mohamed Zerara, Benjamin Marande, Raquel Vivet-Noguer, Ensar Halilovic, Claire Fabre, Aart Jochemsen, Sergio Roman-Roman, Samar Alsafadi

(2020 01 Feb)

2019

Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology

Cancers

Raquel Vivet-Noguer, Malcy Tarin, Sergio Roman-Roman, Samar Alsafadi

(2019 20 Jul)